Myeloma research

We strive to advance the treatments to fight myeloma, and therefore patients, who are cared for at Institut Curie and who provide us with their authorization, have the opportunity to participate in therapeutic trials. Institut Curie is strongly involved in the myeloma clinical research network (IFM: French-speaking Myeloma Intergroup).